MedPath

the study is comparing two drugs, one called heat stable Carbetocin and the other called Oxytocin, to see which one works better in preventing excessive bleeding after vaginal childbirth by helping the uterus contract properly

Phase 3
Conditions
Health Condition 1: O721- Other immediate postpartum hemorrhage
Registration Number
CTRI/2024/05/066741
Lead Sponsor
Dr Suraj Ashokrao Mokade
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age 18 TO 35 years

Pregnant patients with gestational age more than or equal to 37 weeks

Singleton pregnancy with cephalic presentation

Expected to deliver vaginally with cervical dilatation more than or equal to 5 cm

Hemoglobin more than 9gm in recent 3rd trimester report

Willing to participate in the study

Exclusion Criteria

Previous lower segment caesarean section

High risk including antepartum haemorrhage traumatic Postpartum haemorrhage

abruption placenta recurrent pregnancy loss multiple pregnancies polyhydramnios

perineal or cervical tears during Labour and delivery

Medical disorders such as coagulation disorder thrombocytopenia renal disorder hepatic disorder severe cardiac disorder asthma epilepsy

Patients with previous uterine surgery

Patients requiring blood transfusion before delivery

Patient allergy to carbetocin

Patients are not willing to sign informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
THE PROPERTION OF WOMEN HAVING BLOOD LOSS MORE THAN 500 ML WITH IN 2 HOUR OF DELIVERY .Timepoint: THE PROPERTION OF WOMEN HAVING BLOOD LOSS MORE THAN 500 ML WITH IN 2 HOUR OF DELIVERY .
Secondary Outcome Measures
NameTimeMethod
the proportion of women requiring additional uterotonics in active managment of third stage of labour <br/ ><br>the proportion of women requiring blood transfusion <br/ ><br>mean hb difference between the two groups <br/ ><br>adverse effects of the drug in the two groups after 48 hour . <br/ ><br>Timepoint: .
© Copyright 2025. All Rights Reserved by MedPath